Kristof Vercruysse

Kristof Vercruysse has a wealth of experience in the biopharmaceutical industry. Kristof began their career in 2001 as a Medical Representative for UNDA. In 2003, they became a Clinical Research Associate for PRA International, then a Senior Clinical Research Associate for Organon NV in 2005. In 2006, they were a Trial Manager for Nycomed, and in 2007 they became a Director of Clinical Operations for Ablynx. From 2013 to 2018, they were the Director of Early Development & Project Management for Sourcia. In 2018, they founded and became the Managing Director of KriVer Consulting. In 2020, they became the Chief Executive Officer of Persomed Life Sciences and the CEO of TargED Biopharmaceuticals. In 2021, they took on the role of Chief Scientific Officer at Ziphius Vaccines.

Kristof Vercruysse attended OLV College Oostende from 1992 to 1998. Kristof then attended Hogeschool West-Vlaanderen - Vlaamse Autonome Hogeschool from 1995 to 1997, where they obtained a Laboratory Technician degree. Finally, they attended Vrije Universiteit Brussel from 1998 to 2001, where they obtained a Master degree in Biomedical Science.